Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Matthew Brouillette
Treatment Discontinuation of Long-Acting Injectables or Oral Atypical Antipsychotics Among Medicaid Recipients With Schizophrenia
Journal of Medical Economics
Health Policy
Related publications
Long-Acting Atypical Antipsychotics: Characterization of the Local Tissue Response
Pharmaceutical Research
Organic Chemistry
Biotechnology
Molecular Medicine
Pharmacology
Pharmaceutical Science
What Is the Role of Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia?
Journal of Clinical Psychiatry
Medicine
Psychiatry
Mental Health
Antipsychotic Monotherapy and Polypharmacy in the Naturalistic Treatment of Schizophrenia With Atypical Antipsychotics
BMC Psychiatry
Psychiatry
Mental Health
The Long-Term Treatment of Schizophrenia With Antipsychotics: A Perennial Debate
World Psychiatry
Psychiatry
Mental Health
Psychiatric Mental Health
Pmh23 - Real-World Costs and Budget Impact of Long-Acting Injection Atypical Antipsychotics for the Management of Schizophrenia in France
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Metabolic Effects of Treatment With Atypical Antipsychotics
Journal of Clinical Psychiatry
Medicine
Psychiatry
Mental Health
Adherence Patterns Among Patients Using Oral Atypical Antipsychotics and Other Medications
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Changes in Glucose and Cholesterol Levels in Patients With Schizophrenia Treated With Typical or Atypical Antipsychotics
American Journal of Psychiatry
Psychiatry
Mental Health
Caregiver Burden in Schizophrenia Following Paliperidone Palmitate Long Acting Injectables Treatment: Pooled Analysis of Two Double-Blind Randomized Phase Three Studies
npj Schizophrenia
Psychiatry
Mental Health
